Jan 12, 2021 / 07:50PM GMT
Christopher Thomas Schott - JPMorgan Chase & Co, Research Division - Senior Analyst
Good afternoon, everybody. I'm Chris Schott at JPMorgan. I'm very pleased to be introducing Endo today. From the company we have, Blaise Coleman, the company's President and CEO.
As a reminder, we are going to have Blaise make a presentation here and then we'll open up to a Q&A session. (Operator Instructions)
With that, let me turn it over to Blaise for the presentation.
Blaise Coleman - Endo International plc - President, CEO & Director
Good afternoon, Chris, and it's good to be with you. And I really appreciate the opportunity to present at today's conference and appreciate the interest by all those watching and listening.
I am joined here at the conference by our CFO, Mark Bradley, and our Global Head of Commercial Operations, Patrick Barry, as well as our Investor Relations team.
I've had the privilege of being Endo's CEO for the last 10 months. And this has been my first opportunity to speak here at the JPMorgan healthcare
Endo International PLC at JPMorgan Healthcare Conference (Virtual) Transcript
Feb 13, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers